- Home
- DCTH vs ACNB Comparison
DCTH vs ACNB Comparison
Compare DCTH & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- ACNB
- Stock Information
- Founded
- DCTH 1988
- ACNB 1857
- Country
- DCTH United States
- ACNB United States
- Employees
- DCTH N/A
- ACNB N/A
- Industry
- DCTH Medical/Dental Instruments
- ACNB Major Banks
- Sector
- DCTH Health Care
- ACNB Finance
- Exchange
- DCTH Nasdaq
- ACNB Nasdaq
- Market Cap
- DCTH 394.9M
- ACNB 450.1M
- IPO Year
- DCTH N/A
- ACNB N/A
- Fundamental
- Price
- DCTH $10.96
- ACNB $41.46
- Analyst Decision
- DCTH Strong Buy
- ACNB Strong Buy
- Analyst Count
- DCTH 4
- ACNB 4
- Target Price
- DCTH $24.00
- ACNB $50.00
- AVG Volume (30 Days)
- DCTH 710.7K
- ACNB 20.0K
- Earning Date
- DCTH 08-06-2025
- ACNB 07-24-2025
- Dividend Yield
- DCTH N/A
- ACNB 3.29%
- EPS Growth
- DCTH N/A
- ACNB N/A
- EPS
- DCTH N/A
- ACNB 2.69
- Revenue
- DCTH $53,850,000.00
- ACNB $123,053,000.00
- Revenue This Year
- DCTH $162.10
- ACNB $40.18
- Revenue Next Year
- DCTH $32.97
- ACNB $4.83
- P/E Ratio
- DCTH N/A
- ACNB $15.37
- Revenue Growth
- DCTH 1068.87
- ACNB 15.31
- 52 Week Low
- DCTH $7.17
- ACNB $35.37
- 52 Week High
- DCTH $18.23
- ACNB $50.72
- Technical
- Relative Strength Index (RSI)
- DCTH 42.66
- ACNB 43.13
- Support Level
- DCTH $10.44
- ACNB $40.80
- Resistance Level
- DCTH $11.67
- ACNB $42.24
- Average True Range (ATR)
- DCTH 0.46
- ACNB 0.80
- MACD
- DCTH 0.11
- ACNB -0.20
- Stochastic Oscillator
- DCTH 68.03
- ACNB 31.08
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.